secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2023-02-27T23:59:59+00:00
Accession:  0001217234-23-000043
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx Q4 revenue $82.4M (+4% YoY); net loss widens to $18.3M; guides for H1 2023 EBITDA profitability
--------------------------------------------------------------------------------

- Full year 2022 revenue $321.8M (+9% YoY); testing volumes up 19% to ~182,000 tests.
- Q4 net loss $18.3M ($0.34 loss per share) vs $16.2M loss in Q4 2021; non-GAAP net loss $3.7M.
- Adjusted EBITDA loss $3.7M in Q4 vs $1.4M loss; full year adjusted EBITDA loss $17.5M vs gain of $17.8M in 2021.
- Cash and marketable securities $293M, no debt; authorized $50M share buyback, repurchased $0.6M in Q4.
- Management targets adjusted EBITDA profitability in first half of 2023; ISHLT guidelines expanded use of HeartCare solutions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723423000043/0001217234-23-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723423000043/cdna-20230227.htm
  HTML page:      https://secwatch.observer/filing/0001217234-23-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer